.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
Express Scripts
Moodys
Accenture
McKinsey
Boehringer Ingelheim
QuintilesIMS
Julphar

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,233,068

« Back to Dashboard

Which drugs does patent 9,233,068 protect, and when does it expire?


Patent 9,233,068 protects OTIPRIO and is included in one NDA.

This patent has one hundred and nineteen patent family members in nineteen countries.

Summary for Patent: 9,233,068

Title:Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
Abstract: Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s): Lichter; Jay (San Diego, CA), Trammel; Andrew M. (Olathe, KS), Piu; Fabrice (San Diego, CA), Ye; Qiang (San Diego, CA), Dellamary; Luis A. (San Marcos, CA), Lebel; Carl (Malibu, CA), Harris; Jeffrey P. (La Jolla, CA)
Assignee: OTONOMY, INC. (San Diego, CA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA)
Application Number:13/645,126
Patent Claim Types:
see list of patent claims
Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Otonomy IncOTIPRIOciprofloxacinINJECTABLE, SUSPENSION;OTIC207986-001Dec 10, 2015RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 9,233,068

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,680,082Controlled release corticosteroid compositions and methods for the treatment of otic disorders► Subscribe
9,132,087Auris formulations for treating otic diseases and conditions► Subscribe
9,603,796Controlled release antimicrobial compositions and methods for the treatment of otic disorders► Subscribe
8,846,770Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders► Subscribe
8,496,957Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders► Subscribe
8,658,626Controlled release corticosteroid compositions and methods for the treatment of otic disorders► Subscribe
8,030,297Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders► Subscribe
9,333,171Controlled-release CNS modulating compositions and methods for the treatment of otic disorders► Subscribe
9,205,048Controlled release antimicrobial compositions and methods for the treatment of otic disorders► Subscribe
8,852,626Controlled-release CNS modulating compositions and methods for the treatment of otic disorders► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,233,068

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
TaiwanI450732► Subscribe
Taiwan201008598► Subscribe
TaiwanI412370► Subscribe
Taiwan201004633► Subscribe
TaiwanI382839► Subscribe
Taiwan200950787► Subscribe
Russian Federation2012139802► Subscribe
Russian Federation2499592► Subscribe
Russian Federation2010147298► Subscribe
Russian Federation2495662► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
US Department of Justice
US Army
Novartis
Baxter
Queensland Health
Julphar
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot